This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

TOLERANCE
Loading...

Levitsky, Josh


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, Reyes J, Klintmalm GB, Demetris AJ, Burrell BE, Priore A, Bridges ND, Sayre PH. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Am J Transplant. 2019 May;19(5):1397-1409. doi: 10.1111/ajt.15205. Epub 2018 Dec 31. Erratum in: Am J Transplant. 2019 Aug;19(8):2393. PubMed PMID: 30506630; PubMed Central PMCID: PMC6482056.
7.338
79
1
Levitsky J. Operational tolerance: past lessons and future prospects. Liver Transpl. 2011 Mar;17(3):222-32. doi: 10.1002/lt.22265. Review. PubMed PMID: 21384504.
4.57
59
1
Levitsky J, Feng S. Tolerance in clinical liver transplantation. Hum Immunol. 2018 May;79(5):283-287. doi: 10.1016/j.humimm.2017.10.007. Epub 2017 Oct 18. Review. PubMed PMID: 29054397.
2.412
58
3
Jucaud V, Shaked A, DesMarais M, Sayre P, Feng S, Levitsky J, Everly MJ. Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients. Hepatology. 2019 Mar;69(3):1273-1286. doi: 10.1002/hep.30281. Epub 2019 Feb 8. PubMed PMID: 30229989.
14.679
44
1
Levitsky J, Burrell BE, Kanaparthi S, Turka LA, Kurian S, Sanchez-Fueyo A, Lozano JJ, Demetris A, Lesniak A, Kirk AD, Stempora L, Yang GY, Mathew JM. Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus. Hepatology. 2019 Nov 13. doi: 10.1002/hep.31036. [Epub ahead of print] PubMed PMID: 31721246; PubMed Central PMCID: PMC7217743.
14.679
38
1
Issa F, Strober S, Leventhal JR, Kawai T, Kaufman DB, Levitsky J, Sykes M, Mas V, Wood KJ, Bridges N, Welniak LA, Chandran S, Madsen JC, Nickerson P, Demetris AJ, Lakkis FG, Thomson AW. The Fourth International Workshop on Clinical Transplant Tolerance. Am J Transplant. 2020 Jun 12. doi: 10.1111/ajt.16139. [Epub ahead of print] PubMed PMID: 32529725.
7.338
17
1
Xie Y, Wu Y, Xin K, Wang JJ, Xu H, Ildstad ST, Leventhal J, Yang GY, Zhang Z, Levitsky J. Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. Transplantation. 2017 May;101(5):1056-1066. doi: 10.1097/TP.0000000000001684. PubMed PMID: 28187014.
4.546
12
1
Tang Q, Leung J, Peng Y, Sanchez-Fueyo A, Lozano JJ, Lam A, Lee K, Greenland JR, Hellerstein M, Fitch M, Li KW, Esensten JH, Putnam AL, Lares A, Nguyen V, Liu W, Bridges ND, Odim J, Demetris AJ, Levitsky J, Taner T, Feng S. Selective decrease of donor-reactive T(regs) after liver transplantation limits T(reg) therapy for promoting allograft tolerance in humans. Sci Transl Med. 2022 Nov 2;14(669):eabo2628. doi: 10.1126/scitranslmed.abo2628. Epub 2022 Nov 2. PubMed PMID: 36322627.
19.319
11
Levitsky J. Immunosuppression withdrawal following liver transplantation: the older, the wiser… but maybe too late. Hepatology. 2013 Nov;58(5):1529-32. doi: 10.1002/hep.26576. Epub 2013 Oct 8. PubMed PMID: 23775780.
14.679
6
1
Cheung A, Levitsky J. Follow-up of the Post-Liver Transplantation Patient: A Primer for the Practicing Gastroenterologist. Clin Liver Dis. 2017 Nov;21(4):793-813. doi: 10.1016/j.cld.2017.06.006. Epub 2017 Aug 8. Review. PubMed PMID: 28987263.
4.623
5
1
Mathew JM, Kurian S, Cravedi P, Tambur A, Guo K, Zhao L, Levitsky J. Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantation. Hum Immunol. 2020 Nov 16. pii: S0198-8859(20)30419-5. doi: 10.1016/j.humimm.2020.10.012. [Epub ahead of print] PubMed PMID: 33213941.
2.412
4
3
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022 Jan 1;106(1):106-116. doi: 10.1097/TP.0000000000003681. PubMed PMID: 33982909; PubMed Central PMCID: PMC8349377.
4.546
3
Bhat M, Pasini E, Patel P, Yu J, Baciu C, Kurian SM, Levitsky J. Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients. Cancer Med. 2022 Oct 7. doi: 10.1002/cam4.5271. [Epub ahead of print] PubMed PMID: 36205189.
4.711
1
Harrington CR, Yang GY, Levitsky J. Advances in Rejection Management: Prevention and Treatment. Clin Liver Dis. 2021 Feb;25(1):53-72. doi: 10.1016/j.cld.2020.08.003. Epub 2020 Oct 26. Review. PubMed PMID: 33978583.
4.623
1
Celaj S, Levitsky J. Profiling the liver graft. Curr Opin Organ Transplant. 2020 Dec 4. doi: 10.1097/MOT.0000000000000834. [Epub ahead of print] PubMed PMID: 33278149.
2.571
1
3
Tanimine N, Markmann JF, Wood-Trageser MA, Demetris AJ, Mason K, Silva JAF, Levitsky J, Feng S, Humar A, Emond JC, Shaked A, Klintmalm G, Sanchez-Fueyo A, Lesniak D, Breeden CP, Nepom GT, Bridges ND, Goldstein J, Larsen CP, DesMarais M, Gaile G, Chandran S. Donor-specific Immune Senescence as a Candidate Biomarker of Operational Tolerance Following Liver Transplantation in Adults: Results of a Prospective, Multicenter Cohort Study. Am J Transplant. 2024 Nov 4:S1600-6135(24)00682-8. doi: 10.1016/j.ajt.2024.10.022. Online ahead of print. PubMed PMID: 39505152.
8.9
Dybala M, Saravanan N, Levitsky J. CON: It's time for new strategies to optimize liver transplant immunosuppression. Liver Transpl. 2025 Jan 20. doi: 10.1097/LVT.0000000000000572. Online ahead of print. No abstract available. PubMed PMID: 39819866.
4.7

Data Sources

PubMed
NCBI
SemanticScholar
Web of Science
Human Phenotype ontology
KEGG
IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

E-mail

Phones

+34 968885229
+34 968885239
+34 968885249

Advanced Charts